Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.00 HKD | +4.21% |
|
-2.89% | +261.11% |
06-17 | RemeGen Receives EU Orphan Drug Designation for Myasthenia Gravis | MT |
06-17 | Remegen's Telitacicept Received Orphan Drug Designation From EMA For Myasthenia Gravis | RE |
Chart calendar RemeGen Co., Ltd.
d7fc8dad0d84aa5e1e4faa8973.2XN2cT7dZnG0YofOX-FKjUH1Qf2k-qa62TmkuIARNFA.tBQZLki5XgeAOr-gFa4Cxja4Mbruz_TdqXXL4bh4fSKsORsTerEFOM4Pxg~82a883999c473c03e043988fb7a51e0b
Upcoming events on RemeGen Co., Ltd.
Past events on RemeGen Co., Ltd.
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 768 828 -7.29% | 1 083 1 129 -4.09% | 1 717 1 737 -1.16% | 2 344 | 3 537 | 4 403 |
EBITDA Million CNY | Released Forecast Spread | -794 -797 0.34% | -1 322 -1 043 -26.73% | -1 214 -1 216 0.19% | -592 | 21,7 | 671 |
EBIT Million CNY | Released Forecast Spread | -981 -966 -1.5% | -1 502 -1 116 -34.59% | -1 456 -1 536 5.23% | -847 | -230 | 388 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -999 -912 -9.56% | -1 511 -1 209 -25.04% | -1 468 -1 527 3.87% | -957 | -208 | 462 |
Net income Million CNY | Released Forecast Spread | -999 -965 -3.53% | -1 511 -1 417 -6.66% | -1 468 -1 527 3.87% | -951 | -203 | 477 |
EPS CNY | Released Forecast Spread | -1,88 -1,82 -3.38% | -2,80 -2,24 -24.7% | -2,73 -2,74 0.46% | -1,73 | -0,38 | 0,84 |
Announcement Date | 27/02/23 | 23/02/24 | 27/02/25 | - |
Quarterly results
Fiscal Period | March | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 307 361 -15.05% | 657 711 -7.59% | 409 376 8.84% | 740 707 4.62% | 467 470 -0.61% | 501 449 11.64% | 970 918 5.72% | |
EBIT Million CNY | Released Forecast Spread | -284 -395 28.02% | |||||||
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | -481 520 -192.43% | -808 847 -195.38% | -432 -485 11.02% | -780 -833 6.31% | -291 -425 31.54% | -397 -380 -4.46% | -688 -671 -2.52% | |
Net income Million CNY | Released Forecast Spread | -481 -520 7.57% | -808 -847 4.62% | -349 | -432 -485 11.02% | -780 -833 6.31% | -291 -425 31.54% | -397 -380 -4.46% | -688 -671 -2.52% |
EPS CNY | Released Forecast Spread | -0,65 | |||||||
Announcement Date | 23/02/24 | 23/02/24 | 26/04/24 | 16/08/24 | 16/08/24 | 29/10/24 | 27/02/25 | 27/02/25 |
More events
Past sector events for RemeGen Co., Ltd.
2025-06-12 | SANBIO COMPANY LIMITED: Q1 2025 Earnings Release |
2025-06-09 02:46 | LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release |
2025-06-05 04:21 | PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release |
2025-05-15 08:00 | TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release |
2025-05-14 | LIGACHEM BIOSCIENCES INC.: Q1 2025 Earnings Release |
2025-05-14 | PEPTRON, INC.: Q1 2025 Earnings Release |
2025-05-14 | OLIX PHARMACEUTICALS, INC: Q1 2025 Earnings Release |
2025-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2025 Earnings Release |
2025-05-14 07:00 | SCHOLAR ROCK HOLDING CORPORATION: Q1 2025 Earnings Release |
2025-05-13 21:00 | BELITE BIO, INC: Q1 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 9995 Stock
- Calendar RemeGen Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition